GTR 90113743

Bids Are Invited For Price Registration For Future And Possible Acquisitions Of Oncological Medicines Part 1 - Annual Plan 2025, According To The Technical Specifications Contained In Annex I Of This Notice

ICB — International Competitive Bid Closed South America
Tender Information
GTR Reference
90113743
Tendering Authority
Subscribe to view
Tender No
298/2024
Financer Name
Self-Funded
Work Title
Bids Are Invited For Price Registration For Future And Possible Acquisitions Of Oncological Medicines Part 1 - Annual Plan 2025, According To The Technical Specifications Contained In Annex I Of This Notice
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
30-12-2024 Closed
Work Detail
Abiraterone, Acetate Concentration/Dosage 250 Mg, Tablet Pharmaceutical Form, Oral Administration Route, Folinic Acid Salt Concentration/Dosage 50 Mg, Pharmaceutical Form In Ampoule Vial, Injectable Solution, Injectable Administration Route, Recombinant Human Epoetin Alpha Concentration/Dosage 40,000 Ui/Ml, Formafarmaceutica Injectable Solution, Presentation Form In Prefilled Syringe, Intravenous Or Subcutaneous Administration Route, Anastrozole Concentration/Dosage 1 Mg, In Blister Or Strip, Fosaprepitant 150 Mg In Lyophilized Powder Injectable Iv In Vial With 10 Ml, Vial, Oral, Onco Bcg Bacillus Calmette Guerin, Containing Attenuated Strains Of Mycobacterium Bovis, Concentration/Dosage 40 Mg, Pharmaceutical Form Lyophilized Powder For Injectable Suspension, Presentation Form Vial, Intravesical Route Of Administration, Bicalutamide Concentration/Dosage 50 Mg, Pharmaceutical Form Coated Tablet, Brentuximab Vedotina Brentuximab Vedotin 50 Mg, Lyophilized Powder For Concentrate For Infusion Solution In Single Use Vial Containing 50 Mg Debrentuximab Vedotin, As Stated In The Product Description, Capecitabine Concentration/Dosage 500Mg, Blister Or Strip, Carboplatin Concentration/Dosage 10 Mg/Ml, Form Farmaceutica Injectable Solution, Via De Intravenous Administration, Carboplatin Concentration/Dosage 10Mg 45Ml, Cetuximab Concentration/Dosage 100 Mg/Ml, Cyclophosphamide Concentration/Dosage 1 G, Pharmaceutical Form Lyophilized Powder For Injectable Solution, Parenteral Route Of Administration, Cyclophosphamide Concentration/Dosage 50 Mg, Cisplatin Concentration/Dosage 1Mg/Ml With 10Ml, Cisplatin Concentration/Dosage 1Mg/Ml With 50Ml, Cytarabine Concentration/Dosage 100 Mg/Ml, Cytarabine Concentration/Dosage 500 Mg, Route Of Administration By Infusion Or Intravenous Injection, Cladribine Concentration/Dosage 1 Mg/Ml, Chlorambucil Concentration/Dosage 2 Mg, Dacarbazine Concentration/Dosage 200 Mg, Dactinomycin Concentration/Dosage 0.5 Mg, Pharmaceutical Form Lyophilized Powder For Injection Solution, Dasatinib Concentration/Dosage 100 Mg, Dasatinib Concentration/Dosage 20 Mg, Daunorubicin, Hydrochloride Concentration/Dosage 20 Mg, Lyophilized Pharmaceutical Form For Injectable Solution, Presentation Form Ampoule Diluent Vial, Decitabine Concentration/Dosage 50 Mg, Diethylstilbestrol Concentration/Dosage 1 Mg, Blister Or Strip Presentation Form, Docetaxel Concentration/Dosage 20Mg, Pharmaceutical Form Powder For Injectable Solution, Docetaxel Concentration/Dosage 80Mg, Doxorubicin Concentration/Dosage 10 Mg, Doxorubicin Concentration/Dosage 50 Mg, Epirubicin, Hydrochloride Concentration/Dosage 10 Mg, Polyophilized Pharmaceutical Form For Injectable Solution, Route Of Administration Intravenous Or Intravesical, Hydrochloride Concentration/Dosage 2 Mg/Ml, Pharmaceutical Form, Injectable Solution, Route Of Administration Intravenous Or Intravesical, Etoposide Concentration/Dosage 20 Mg/Ml, Presentation Form Vial With 5 Ml, Everolimus Concentration/Dosage 10 Mg, Route Of Administration Oral, Exemestane Concentration/Dosage 25 Mg, Packed In Blister Or Strip, Filgrastima Concentration/Dosage 300 Mcg/Ml, Fludarabine, Phosphate Concentration/Dosage 50 Mg, Presentation Form Diluent Ampoule Bottle, Fluorouracil Concentration/Dosage 50Mg/Ml, Pharmaceutical Form Solution Injectable In 10Ml Ampoule Bottle, Pharmaceutical Form Injectable Solution In 50Ml Ampoule Bottle, Intravenous Administration Route, Flutamide Concentration/Dosage 250 Mg
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
e91ae384-072c-482a-95c5-c8dd021e6d45.html
Attachments
Additional Details Available on Click
  • Tendering Authority
  • Publication Document (Tender Document / Tender Notice)
Disclaimer

We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.

Tell us about your Product / Services,

We will Find Tenders for you

TenderDetail
Loading tenders